Site içinde arama yapın

bir dosya eklendi Health

2026-01-14 09:13:54 -

Anxiolytic Market: Can "Psychedelic Science" Provide a Breakthrough for Treatment Resistance?

The medical community is witnessing a historic turning point with the emergence of psychedelic-derived compounds in the pipeline for 2026. Investigational treatments like MM120—a precisamente controlled dose of a lysergic acid diethylamide (LSD) derivative—are moving through late-stage clinical trials for generalized anxiety disorder. Unlike traditional daily pills, these therapies...

0 Yorumlar 0 hisse senetleri 336 Views